Key terms

About VTVT

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VTVT news

Apr 10 5:14pm ET vTv Therapeutics files $250M mixed securities shelf by TipRanks Mar 14 8:12am ET vTv Therapeutics Appoints Anne Phillips, Reshuffles Board Committees by TipRanks Mar 13 8:05am ET vTv Therapeutics expects cash to fund operations through Phase 3 study data by TipRanks Mar 13 8:04am ET vTv Therapeutics reports Q4 EPS ($1.67) vs. ($2.28) last year by TipRanks Mar 05 8:23am ET vTv Therapeutics Enhances Investor Communication with Update by TipRanks Mar 04 8:04am ET vTv Therapeutics announces FDA submission for Phase 3 study of cadisegliatin by TipRanks Mar 01 11:04am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 28 11:26am ET vTv Therapeutics trading resumes by TipRanks Feb 28 11:16am ET vTv Therapeutics trading halted, volatility trading pause by TipRanks Feb 28 8:22am ET vTv Therapeutics Secures $51M Through Private Placement and Warrants by TipRanks Feb 28 8:12am ET vTv Therapeutics reduces board to seven members from nine by TipRanks Jan 26 11:25am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 25 11:38am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 25 11:38am ET Biotech Alert: Searches spiking for these stocks today by TipRanks

No recent press releases are available for VTVT

VTVT Financials

1-year income & revenue

Key terms

VTVT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VTVT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments